Eiger BioPharmaceuticals Inc. (EIGR) Declined -7.44% or -0.72 To Price $9.03 On Monday


Eiger BioPharmaceuticals Inc. (EIGR) declined -7.44% or -0.72 to $9.03. It is nearly 50091 shares traded, which is 70.16% compare to the average total volume 71394. The market cap of EIGR is $94.91 million. The year to date change is -30.6%. The 52 week price range is from $6.1 to $16.2. Price of EIGR have changed 3.17% during last week. It have changed 12.72% over last month, -21.05% over last 3 months, -7.14% over last 6 months and -17.02% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for EIGR is 10.17. It is 12.62% above current price. The 200-day Moving Averages for EIGR is 9.85. It is 9.08% above current price. The 52-week High is 16.2. It is 79.40% from the current price. The 52-week Low is 6.1. It is -32.45% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of EIGR is 5.53 on 2018-02-28. Short % to float is 4.08%. There are some statistics of EIGR. It is has market cap $94.91 million. The share outstanding is 10.52 million. The average volume is 71394. It has 181.61M cash and 14.73M in debt. The percent of top 15 Institution holding is 36.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of EIGR is -137.18%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of EIGR is -97.73%.


Tags:

Share this post